SHMT1 and ovarian carcinoma: To determine if loss of SHMT1 effects ovarian cancer tumor growth in vivo, we injected ovarian cancer cell lines expressing either shRNA targeting SHMT1 or a nonspecific shRNA subcutaneously into the flanks of the athymic nude mice and measured tumor volume at specific time points after injection.